Author:
Jiang J,Zhang Y,Chuai S,Wang Z,Zheng D,Xu F,Zhang Y,Li C,Liang Y,Chen Z
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference72 articles.
1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF . (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983–3988.
2. Araki H, Yoshinaga K, Boccuni P, Zhao Y, Hoffman R, Mahmud N . (2007). Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 109: 3570–3578.
3. Bernstein ID, Tam MR, Nowinski RC . (1980). Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science 207: 68–71.
4. Beuzeboc P, Scholl S, Garau XS, Vincent-Salomon A, Cremoux PD, Couturier J et al. (1999). Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene? Bull Cancer 86: 544–549.
5. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP et al. (2010). Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133–137.
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献